MARNUR Unveils Walmart Black Friday Deals with Wellness Favorites — A Top Pick for Holiday Gifting Season

AsWalmart officially kicks off its AE2 Black Friday Event from November 25-30, leading home-wellness brand MARNUR announces a standout lineup of deep discounts across its best-selling massage and heating essentials. Arriving just as “cozy season” sets in and holiday gift searches reach their peak, MARNUR's Black Friday offerings aim to elevate home comfort, ease daily […]

Social Labs AI Strengthens Digital Intelligence Portfolio with NRM(TM) and SEA(TM) Launch

San Francisco, California–(Newsfile Corp. – November 25, 2025) – Social Labs AI has expanded its enterprise-focused behavioral intelligence capabilities with the introduction of two new systems: the Neural Redirect Matrix (NRM™) and the Sentient Exposure Amplifier (SEA™). Both technologies, recently secured under trademark protections, are entering controlled enterprise deployment through a closed-access model that includes

Hong Kong to Host International Summit on Heart and Brain Health, Spotlighting AI and Startup Innovations

The2nd International Cerebro-cardiovascular Medical Innovation Summit (ICMIS 2025)will bring together global leaders to discuss cutting-edge research, innovative medical products, and cross-border collaborations to accelerate progress toward advanced cerebro-cardiovascular care worldwide. Hosted by the InnoHK Hong Kong Centre for Cerebro-cardiovascular Health Engineering (COCHE), the summit will serve as a unique and premium platform uniting leading clinicians,

Avantor, Inc. (AVTR) Investors: December 29, 2025 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

SAN FRANCISCO, CA / ACCESS Newswire / November 25, 2025 / National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Avantor, Inc. ("Avantor" or the "Company") (NYSE:AVTR) who purchased or otherwise acquired Avantor common stock between March 5, 2024 and October 28, 2025, inclusive (the "Class Period") to contact us immediately

Elton John AIDS Foundation and Zipline: $150M US State Department Boost Accelerates HIV Care Innovation

The Elton John AIDS Foundation (EJAF) today celebrates Zipline's $150 million funding from the U.S. State Department to triple its lifesaving drone delivery network, a milestone that builds on the Foundation's catalytic early support and cements their role in pioneering drone-enabled HIV care across Africa. The award is based on a first-of-its-kind pay-for-performance model, demonstrating

Lunai Bioworks Secures First Licensing LOI Following Landmark Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models

Following peer-reviewed publication and independent expert review of findings, the LOI advances Lunai's tumor-regressing immune-cell platform toward scalable therapies for aggressive cancers Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, today announced it has secured its first Letter of Intent (LOI) to license its next-generation immune cell therapy, which achieved complete regression

Jacobs to Manage Infrastructure Development Program to Support Regional Growth in El Paso, Texas

Advancing water systems to support economic growth and resiliency Jacobs (NYSE: J) has been selected by El Paso Water to provide program management and owner's representative services for its Utility Infrastructure Development Program near El Paso International Airport and Fort Bliss, one of the largest military installations in the U.S. Jacobs will lead program planning

Baxter International, Inc. (BAX) Investors: December 15, 2025 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

SAN FRANCISCO, CA / ACCESS Newswire / November 25, 2025 / National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Baxter International, Inc. ("Baxter") (NYSE:BAX) who purchased or otherwise acquired Baxter common stock between February 23, 2022 and July 30, 2025, inclusive (the "Class Period") to contact us immediately regarding the

MoonLake Immunotherapeutics (MLTX) Shareholders Get Answers in Latest SueWallSt Podcast

NEW YORK, NY / ACCESS Newswire / November 25, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding MoonLake Immunotherapeutics (NASDAQ:MLTX) class action securities lawsuit A Class Action lawsuit was filed on behalf of MoonLake Immunotherapeutics investors who lost money as a result of alleged securities fraud between March 10, 2024 and September 29,

aTyr Pharma, Inc. (ATYR) Shareholders Get Answers in Latest SueWallSt Podcast

NEW YORK, NY / ACCESS Newswire / November 25, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding aTyr Pharma, Inc. (NASDAQ:ATYR) class action securities lawsuit A Class Action lawsuit was filed on behalf of aTyr Pharma, Inc. investors who lost money as a result of alleged securities fraud between November 7, 2024 and

Scroll to Top